These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1414376)

  • 21. Opposing effects of tyrosine kinase inhibitors on mineralization of normal and tumor bone cells.
    Klein BY; Tepper SH; Gal I; Shlomai Z; Ben-Bassat H
    J Cell Biochem; 1997 Jun; 65(3):420-9. PubMed ID: 9138097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor.
    Rewcastle GW; Bridges AJ; Fry DW; Rubin JR; Denny WA
    J Med Chem; 1997 Jun; 40(12):1820-6. PubMed ID: 9191958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Benzylidene-5 pyrrolones, furanones and thiophenones. 2. Quantitative structure-activity relationship].
    Galdino SL; Pitta IR; Luu-Duc C
    Farmaco Sci; 1986 Jan; 41(1):59-68. PubMed ID: 3956721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors.
    Han Y; Caday CG; Nanda A; Cavenee WK; Huang HJ
    Cancer Res; 1996 Sep; 56(17):3859-61. PubMed ID: 8752145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
    Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
    J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of 5-benzylidene barbiturate derivatives on mushroom tyrosinase and their antibacterial activities.
    Yan Q; Cao R; Yi W; Chen Z; Wen H; Ma L; Song H
    Eur J Med Chem; 2009 Oct; 44(10):4235-43. PubMed ID: 19552984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis and biological activity of tyrosine protein kinase inhibitors].
    Pang SH; Guo ZR; Liang XT
    Yao Xue Xue Bao; 1997 Jul; 32(7):515-23. PubMed ID: 11596277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-linked immunosorbent assay for trkA tyrosine kinase activity.
    Angeles TS; Steffler C; Bartlett BA; Hudkins RL; Stephens RM; Kaplan DR; Dionne CA
    Anal Biochem; 1996 Apr; 236(1):49-55. PubMed ID: 8619495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cinnamamide analogs as inhibitors of protein tyrosine kinases.
    Buzzetti F; Brasca MG; Crugnola A; Fustinoni S; Longo A; Penco S; Dalla Zonca P; Comoglio PM
    Farmaco; 1993 May; 48(5):615-36. PubMed ID: 8343210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an indole-based chemically cleavable linker concept for immobilizing bait compounds for protein pull-down experiments.
    Sturm M; Leitner A; Lindner W
    Bioconjug Chem; 2011 Feb; 22(2):211-7. PubMed ID: 21247093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4(1H)-quinolones.
    Traxler P; Green J; Mett H; Séquin U; Furet P
    J Med Chem; 1999 Mar; 42(6):1018-26. PubMed ID: 10090785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural biology contributions to tyrosine kinase drug discovery.
    Cowan-Jacob SW; Möbitz H; Fabbro D
    Curr Opin Cell Biol; 2009 Apr; 21(2):280-7. PubMed ID: 19208462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial conformation and topography of the tyrosine aromatic ring in substrate recognition by protein tyrosine kinases.
    Ruzza P; Cesaro L; Tourwé D; Calderan A; Biondi B; Maes V; Menegazzo I; Osler A; Rubini C; Guiotto A; Pinna LA; Borin G; Donella-Deana A
    J Med Chem; 2006 Mar; 49(6):1916-24. PubMed ID: 16539378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
    Sevransky JE; Shaked G; Novogrodsky A; Levitzki A; Gazit A; Hoffman A; Elin RJ; Quezado ZM; Freeman BD; Eichacker PQ; Danner RL; Banks SM; Bacher J; Thomas ML; Natanson C
    J Clin Invest; 1997 Apr; 99(8):1966-73. PubMed ID: 9109441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
    Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Rewcastle GW; Palmer BD; Bridges AJ; Showalter HD; Sun L; Nelson J; McMichael A; Kraker AJ; Fry DW; Denny WA
    J Med Chem; 1996 Feb; 39(4):918-28. PubMed ID: 8632415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of some 3-(substituted-benzylidene)-1,3-dihydroindolin derivatives as ligands of tyrosine kinase based on binding mode studies and biological assay.
    Olgen S
    Arch Pharm Res; 2006 Nov; 29(11):1006-17. PubMed ID: 17146970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlative analysis of chemical structure - biological activity using Hansch's method: principles and development of the method].
    Grieco C; Silipo C; Vittoria A
    Farmaco Sci; 1976 Nov; 31(11):824-44. PubMed ID: 1010034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell permeability as a parameter for lead generation in the protein Tyrosine kinase inhibition field.
    Papageorgiou C; Camenisch G; Borer X
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1549-52. PubMed ID: 11412978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.